Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Medicinal Research Reviews | journal | 3.062 Q1 | 150 | 27 | 85 | 5423 | 822 | 85 | 9.41 | 200.85 | |
2 | Frontiers in Medicinal Chemistry | book series | 0.226 Q3 | 7 | 29 | 27 | 4600 | 13 | 26 | 0.00 | 158.62 | |
3 | Current Medicinal Chemistry | journal | 1.758 | 202 | 282 | 767 | 43990 | 4314 | 766 | 5.35 | 155.99 | |
4 | Natural Product Reports | journal | 2.925 Q1 | 211 | 77 | 186 | 11182 | 1455 | 181 | 7.70 | 145.22 | |
5 | Current Molecular Pharmacology | journal | 0.438 Q3 | 49 | 27 | 23 | 3594 | 29 | 23 | 1.26 | 133.11 | |
6 | Current Cancer Drug Targets | journal | 2.329 Q1 | 103 | 75 | 194 | 9712 | 1095 | 185 | 5.45 | 129.49 | |
7 | Recent Patents on CNS Drug Discovery | journal | 0.743 Q2 | 36 | 19 | 70 | 2426 | 195 | 70 | 2.89 | 127.68 | |
8 | Frontiers in Drug Design and Discovery | book series | 0.330 Q3 | 9 | 18 | 41 | 2204 | 31 | 39 | 1.09 | 122.44 | |
9 | Current Gene Therapy | journal | 1.983 Q1 | 80 | 44 | 129 | 5188 | 719 | 126 | 5.86 | 117.91 | |
10 | Current Pharmaceutical Design | journal | 1.605 Q1 | 183 | 349 | 1097 | 40829 | 4830 | 980 | 4.56 | 116.99 | |
11 | Current Enzyme Inhibition | journal | 0.205 Q4 | 19 | 20 | 74 | 2319 | 44 | 74 | 0.69 | 115.95 | |
12 | Current Drug Discovery Technologies | journal | 0.553 Q2 | 49 | 27 | 88 | 2842 | 162 | 86 | 1.94 | 105.26 | |
13 | Expert Opinion on Drug Discovery | journal | 0.463 Q3 | 84 | 92 | 303 | 9533 | 415 | 296 | 1.43 | 103.62 | |
14 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 27 | 55 | 2785 | 42 | 55 | 0.76 | 103.15 | ||
15 | Expert Opinion on Therapeutic Targets | journal | 1.469 Q1 | 106 | 116 | 345 | 11796 | 1225 | 321 | 3.82 | 101.69 | |
16 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.954 Q2 | 52 | 27 | 72 | 2740 | 246 | 72 | 3.07 | 101.48 | |
17 | Current Computer-Aided Drug Design | journal | 0.428 Q3 | 32 | 21 | 82 | 2108 | 135 | 76 | 1.78 | 100.38 | |
18 | Mini-Reviews in Medicinal Chemistry | journal | 0.984 Q2 | 107 | 149 | 394 | 14757 | 1314 | 391 | 3.26 | 99.04 | |
19 | Current Drug Targets | journal | 1.775 Q1 | 119 | 131 | 427 | 12582 | 1765 | 379 | 3.86 | 96.05 | |
20 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.119 Q4 | 28 | 26 | 25 | 2466 | 5 | 25 | 0.20 | 94.85 | |
21 | Topics in Medicinal Chemistry | book series | 15 | 10 | 0 | 913 | 0 | 0 | 0.00 | 91.30 | ||
22 | Current Topics in Medicinal Chemistry | journal | 1.542 Q1 | 133 | 143 | 505 | 12891 | 2045 | 435 | 3.91 | 90.15 | |
23 | Expert Opinion on Therapeutic Patents | journal | 0.477 Q3 | 88 | 109 | 332 | 9508 | 405 | 321 | 1.21 | 87.23 | |
24 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 21 | 74 | 1744 | 152 | 74 | 2.07 | 83.05 | ||
25 | Expert Opinion on Biological Therapy | journal | 1.137 Q1 | 102 | 141 | 454 | 11591 | 1569 | 448 | 3.57 | 82.21 | |
26 | Biomarkers in Medicine | journal | 0.187 Q4 | 56 | 70 | 50 | 5373 | 29 | 41 | 0.58 | 76.76 | |
27 | PPAR Research | journal | 0.952 Q2 | 59 | 39 | 169 | 2968 | 391 | 158 | 2.34 | 76.10 | |
28 | Pharmacognosy Reviews (discontinued) | journal | 68 | 41 | 0 | 3074 | 0 | 0 | 0.00 | 74.98 | ||
29 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.589 Q2 | 30 | 28 | 78 | 2051 | 175 | 78 | 2.29 | 73.25 | |
30 | Current Opinion in Investigational Drugs | journal | 1.276 Q1 | 83 | 136 | 371 | 9871 | 1308 | 339 | 3.66 | 72.58 | |
31 | Expert Review of Vaccines | journal | 1.278 Q1 | 105 | 156 | 310 | 11295 | 1142 | 276 | 3.97 | 72.40 | |
32 | Future Medicinal Chemistry | journal | 90 | 120 | 0 | 8645 | 0 | 0 | 0.00 | 72.04 | ||
33 | Perspectives in Medicinal Chemistry | journal | 0.103 Q4 | 17 | 3 | 7 | 212 | 0 | 7 | 0.00 | 70.67 | |
34 | Current Opinion in Molecular Therapeutics | journal | 1.249 Q1 | 67 | 77 | 212 | 5421 | 730 | 194 | 3.72 | 70.40 | |
35 | Current Opinion in Drug Discovery and Development | journal | 1.722 Q1 | 85 | 73 | 215 | 5063 | 1028 | 197 | 5.07 | 69.36 | |
36 | Molecular Diversity | journal | 0.597 Q2 | 63 | 48 | 97 | 3137 | 295 | 94 | 2.05 | 65.35 | |
37 | HIV Therapy | journal | 14 | 60 | 0 | 3725 | 0 | 0 | 0.00 | 62.08 | ||
38 | Open Vaccine Journal | journal | 10 | 13 | 0 | 772 | 0 | 0 | 0.00 | 59.38 | ||
39 | Drug Development Research | journal | 0.434 Q3 | 67 | 54 | 216 | 3111 | 285 | 204 | 0.70 | 57.61 | |
40 | Combinatorial Chemistry and High Throughput Screening | journal | 0.619 Q2 | 70 | 101 | 256 | 5737 | 607 | 236 | 2.59 | 56.80 | |
41 | Marine Drugs | journal | 0.437 Q3 | 159 | 52 | 69 | 2923 | 177 | 69 | 2.88 | 56.21 | |
42 | Drug News and Perspectives | journal | 0.620 Q2 | 53 | 70 | 225 | 3821 | 350 | 222 | 1.57 | 54.59 | |
43 | Current Opinion in Pharmacology | journal | 3.520 Q1 | 148 | 116 | 305 | 6206 | 2210 | 274 | 7.09 | 53.50 | |
44 | Drug Discovery Today | journal | 1.979 Q1 | 215 | 154 | 459 | 8116 | 2858 | 433 | 6.23 | 52.70 | |
45 | Antiviral Chemistry and Chemotherapy | journal | 0.530 Q2 | 59 | 17 | 79 | 891 | 154 | 77 | 2.12 | 52.41 | |
46 | Tetrahedron | journal | 1.545 Q1 | 236 | 1290 | 3973 | 66897 | 13229 | 3940 | 3.45 | 51.86 | |
47 | Pharmaceuticals | journal | 87 | 23 | 0 | 1175 | 0 | 0 | 0.00 | 51.09 | ||
48 | Drug Design, Development and Therapy | journal | 0.157 Q4 | 94 | 22 | 30 | 1112 | 11 | 27 | 0.37 | 50.55 | |
49 | Drug Discovery Today: Disease Mechanisms | journal | 0.400 Q3 | 28 | 9 | 154 | 431 | 114 | 140 | 0.89 | 47.89 | |
50 | BMC Chemical Biology | journal | 0.634 Q2 | 21 | 7 | 8 | 330 | 15 | 8 | 1.80 | 47.14 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®